The new Russian coronavirus vaccine may enter civilian circulation by autumn, said Alexander Gintsburg, director of the Gamaleya Research Center for Epidemiology and Microbiology.
On the eve of the Ministry of Health allowed clinical trials of the “cocktail of antibodies”: trials of the drug based on monoclonal antibodies will begin in three weeks. As the scientist said, the 2-component vaccine does not contain a live virus, but it will protect against several strains at once, including delta and omicron, the channel reports. “Russia 24”.
Earlier, Gunzburg explained that it is possible to get 100% protection against the omicron strain of coronavirus. Immunity from “omicron” for 3 months will be for those who were revaccinated with “Sputnik Light”. One hundred percent of people boosted in this way have antibodies against “omicron”.